Worth reading
72In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
4200000
¥Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of the 5th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment
Who receives how much
28,000,000 shares (280,000 stock acquisition rights, 100 shares per right)
EVO FUND: 280,000 stock acquisition rights
The lower thin line represents the existing number of shares to which these shares will be added.
¥15 per stock acquisition right
Total issue value
¥4,200,000
Amount of funds to be raised
¥3,224,200,000 (estimated net proceeds: ¥3,215,921,000)
Estimated issuance expenses
¥8,279,000
Terms of the stock acquisition rights
Exercise price
Initially ¥115. From the second trading day after the allotment date, in principle, adjusted to 100% of the lowest closing price among the five consecutive trading days immediately preceding the adjustment date. Floor: ¥58.
Exercise period
From 15 October 2026 to 17 May 2027
Number of Stock Acquisition Rights
Total issued: 280,000 rights. Number of outstanding unexercised rights: Not disclosed.
Reason for acquisition without consideration
After one month has elapsed from the payment date, the company may acquire the rights without consideration if it resolves that acquisition is necessary. All remaining rights will be acquired on 17 May 2027.
Payment date
14 October 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the 5th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment |
| Number of shares to be issued or disposed of | 28,000,000 shares (280,000 stock acquisition rights, 100 shares per right) |
| Issue price and disposal price | ¥15 per stock acquisition right |
| Total issue value | ¥4,200,000 |
| Amount of funds to be raised | ¥3,224,200,000 (estimated net proceeds: ¥3,215,921,000) |
| Estimated issuance expenses | ¥8,279,000 |
| Payment date | 14 October 2026 |
| Intended allottee | EVO FUND: 280,000 stock acquisition rights |
| Exercise price | Initially ¥115. From the second trading day after the allotment date, in principle, adjusted to 100% of the lowest closing price among the five consecutive trading days immediately preceding the adjustment date. Floor: ¥58. |
| Exercise period | From 15 October 2026 to 17 May 2027 |
| Number of Stock Acquisition Rights | Total issued: 280,000 rights. Number of outstanding unexercised rights: Not disclosed. |
| Reason for acquisition without consideration | After one month has elapsed from the payment date, the company may acquire the rights without consideration if it resolves that acquisition is necessary. All remaining rights will be acquired on 17 May 2027. |
Items this document does not state (16)
Specific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price of ¥4,200,000 was completed on 14 October 2026. The purpose and use of the funds raised are not stated in this document.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.